Table 3.

Distribution of hospital complications among patients tested for severe acute respiratory syndrome coronavirus 2

Hospital ComplicationsTotal N=31,540, n (%)PatientsControlsP values
Severe Acute Respiratory Syndrome Coronavirus 2 +/Kidney Transplant Recipients, N=32, n (%)Severe Acute Respiratory Syndrome Coronavirus 2 +/Non-Kidney Transplant Recipients, N=3181, n (%)Severe Acute Respiratory Syndrome Coronavirus 2 −/Kidney Transplant Recipients, N=224, n (%)Severe Acute Respiratory Syndrome Coronavirus 2 −/Non-Kidney Transplant Recipients, N=28,103, n (%)P1P2P3PInteraction
ICU admission6287 (20)11 (34)766 (24)55 (25)5455 (19)0.180.240.030.37
Ventilation1850 (6)11 (34)437 (14)20 (9)1382 (5)<0.001<0.001<0.0010.05
Vasopressor use3799 (12)13 (41)503 (16)37 (17)3246 (12)<0.0010.001<0.0010.01
AKI2882 (9)15 (47)458 (15)51 (23)2358 (10)<0.0010.004<0.0010.07
Inpatient mortality1317 (4)8 (25)498 (16)5 (2)806 (3)0.15<0.001<0.0010.12
  • P values were obtained using the Kruskal-Wallis test. Values in red represent statistically significant differences. P1 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–positive non-KTR, P2 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–negative KTR, P3 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–negative non-KTR, and PInteraction tests the interaction between SARS-CoV-2 and KTR status (a significant interaction P value can be interpreted as the relationship between SARS-CoV-2 infection and outcome is significantly modified by kidney transplant status). ICU, intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; KTR, kidney transplant recipient.